Physician profile
Stacey Obrien
NPI 1164843389
$5,091.08
in general payments reported to CMS, 2019-2025
32 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $233 · 2021: $319 · 2022: $363 · 2023: $827 · 2024: $1,549 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,758 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,758.44 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,048.77 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $723.83 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $589.01 | 2021-2025 | |
| Lilly USA, LLC | $588.73 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $300.08 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astellas Pharma US INC | $275.01 | 2019-2025 | Veozah |
| Merz North America, INC. | $198.22 | 2021-2023 | |
| Amgen INC. | $155.20 | 2019-2025 | Repatha, Otezla, Repatha |
| Insulet Corporation | $152.04 | 2019 | |
| Exact Sciences Corporation | $151.77 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.00 | 2024-2025 | Jardiance |
| Pfizer INC. | $78.76 | 2024-2025 | |
| Antares Pharma, INC. | $77.17 | 2024-2025 | Xyosted |
| Abbott Laboratories | $67.05 | 2022-2024 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.13 | 2024-2025 | Caplyta |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $53.60 | 2024-2025 | Tlando |
| Dynavax Technologies Corporation | $51.41 | 2024 | Heplisav-B |
| Globus Medical, INC. | $50.19 | 2025 | Senza |
| Idorsia Pharmaceuticals US INC | $48.73 | 2024 | Quviviq |
| Merck Sharp & Dohme LLC | $42.54 | 2020-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Almatica Pharma LLC | $39.39 | 2023 | Loreev Xr |
| Inspire Medical Systems, INC. | $37.73 | 2025 | Inspire |
| Sumitomo Pharma America, INC. | $36.56 | 2025 | Gemtesa |
| Vivus LLC | $24.17 | 2023 | Qsymia |
| Philips North America LLC | $21.12 | 2024 | (Ck7) Extended Holter |
| Biotronik Nro, INC. | $19.96 | 2024 | Prospera |
| Halozyme INC | $19.91 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.27 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.59 | 2019 | |
| Nevro Corp. | $17.20 | 2024 | Senza |
| Currax Pharmaceuticals LLC | $14.08 | 2023 | Contrave, Onzetra Xsail |
| Allergan, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.